No profile data available.
Co-Diagnostics, Inc. (CODX) is a healthcare company in the DNA testing equipment industry, based in Salt Lake City, United States, with about 115 full-time employees.
It reported revenue of $622,489 for fiscal year 2025, down 84.1% from fiscal year 2024, and net income of -$46.90 million. In Q1 2026 (the quarter ended March 31, 2026) revenue was $145,954, up 190.3% from a year before. United States was its largest region in fiscal year 2025, with 93% of revenue. Its market capitalization was $7.82 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally.
Co-Diagnostics reported $622,489 in revenue for fiscal year 2025, down 84.1% from $3.92 million in fiscal year 2024. In Q1 2026 revenue was $145,954.
United States: 93% of revenue by region in fiscal year 2025, followed by Rest of World (7%).
$7.82 million as of October 9, 2026.
Listed companies of a similar size in the same industry (DNA testing equipment) include MDxHealth SA (MDXH), PAVmed Inc. (PAVM), Aspira Women's Health Inc. (AWHL), Cardio Diagnostics Holdings, Inc. (CDIO).